0
Research
Safety-focused medication therapy management: A randomized controlled trial
Daniel R. Touchette; Andrew L. Masica; Rowena J. Dolor; Glen T. Schumock; Young Ku Choi; Yoonsang Kim; Scott R. Smith
J Am Pharm Assoc (2003) 2012;52:603-612. doi:10.1331/JAPhA.2012.12036

Abstract

Objective  To evaluate the effect of a medication therapy management (MTM) intervention on adverse drug events (ADEs), health care visits, and drug-related problems (DRPs).

Design  Randomized, controlled, clinical trial.

Setting  Academic medical center community pharmacies and family medicine clinics at three U.S. sites between December 2007 and January 2010

Patients  Individuals aged 65 years or older with three or more chronic illnesses, six or more prescription medications, and at risk for a DRP.

Intervention  At 0 and 3 months, pharmacists conducted comprehensive medication reviews and screened for and resolved DRPs through patient education and recommendations to physicians.

Main outcome measures  Frequency of ADEs reported by patients and confirmed by clinical algorithm, health care visits at 3 and 6 months, and number of DRPs, pharmacist recommendations, and medication discrepancies.

Results  637 participants enrolled. No differences were observed in potential ADEs or health care visits among the usual care and MTM groups. DRPs declined in both MTM intervention groups over time. Physicians responded to 54.6% of pharmacist recommendations. Enhanced MTM patients had fewer medication list discrepancies than basic MTM patients (33.8% vs. 47.1%, P < 0.001).

Conclusion  This specific design of MTM was associated with reduced DRPs but did not reduce potential ADEs or health care visits.

Sign In
APhA Members 
Welcome to JAPhA.org! Please log in below using your APhA username and password. Update your APhA profile.
Not a Subscriber
New to JAPhA? Become an APhA member to receive a full subscription to both the print and online editions.

OR

Register for a FREE limited account to benefit from personalization features such as alerts.

References

Higashi T, Shekelle PG, Solomon DH, et al.  The quality of pharmacologic care for vulnerable older patients.  Ann Intern Med.  2004; 140: 714– 20. [PubMed]
 
Kaufman DW, Kelly JP, Rosenberg L, et al.  Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey.  JAMA.  2002; 287: 337– 44. [PubMed]
 
Qato DM, Alexander GC, Conti RM, et al.  Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States.  JAMA.  2008; 300: 2867– 78. [PubMed]
 
Lichtenberg FR, Sun SX.  The impact of Medicare Part D on prescription drug use by the elderly. Health Aff (Millwood).  2007; 26: 1735– 44.
 
Schneeweiss S, Patrick AR, Pedan A, et al.  The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits. Health Aff (Millwood).  2009; 28: w305– 16.
 
Gurwitz JH, Field TS, Harrold LR, et al.  Incidence and preventability of adverse drug events among older persons in the ambulatory setting.  JAMA.  2003; 289: 1107– 16. [PubMed]
 
Bourgeois FT, Shannon MW, Valim C, Mandl KD.  Adverse drug events in the outpatient setting: an 11-year national analysis.  Pharmacoepidemiol Drug Saf.  2010; 19: 901– 10. [PubMed]
 
Johnson JA, Bootman JL.  Drug-related morbidity and mortality: a cost-of-illness model.  Arch Intern Med.  1995; 155: 1949– 56. [PubMed]
 
Public Law 108–173.  The Medicare Prescription Drug, Improvement, and Modernization Act of 2003. Accessed at www.cms.gov/CCIP/downloads/section_721.pdf,  June 12, 2010.
 
Smith SR, Clancy CM.  Medication therapy management programs: forming a new cornerstone for quality and safety in Medicare.  Am J Med Qual.  2006; 21: 276– 9. [PubMed]
 
McGivney MS, Meyer SM, Duncan-Hewitt W, et al.  Medication therapy management: its relationship to patient counseling, disease management, and pharmaceutical care.  J Am Pharm Assoc.  2007; 47: 620– 8.
 
Touchette DR, Burns AL, Bough MA, Blackburn JC.  Survey of medication therapy management programs under Medicare part D.  J Am Pharm Assoc.  2006; 46: 683– 91.
 
Boyd ST, Boyd LC, Zillich AJ.  Medication therapy management survey of the prescription drug plans.  J Am Pharm Assoc.  2006; 46: 692– 9.
 
Pellegrino AN, Martin MT, Tilton JJ, Touchette DR.  Medication therapy management services: definitions and outcomes.  Drugs.  2009; 69: 393– 406. [PubMed]
 
Bero LA, Lipton HL, Bird JA.  Characterization of geriatric drug-related hospital readmissions.  Med Care.  1991; 29: 989– 1003. [PubMed]
 
van Mil JW, Westerlund LO, Hersberger KE, Schaefer MA.  Drug-related problem classification systems.  Ann Pharmacother.  2004; 38: 859– 67. [PubMed]
 
Nebeker JR, Barach P, Samore MH.  Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting.  Ann Intern Med.  2004; 140: 795– 801. [PubMed]
 
Masica AL, Touchette DR, Dolor RJ, et al.   Evaluation of a medication therapy management program in Medicare beneficiaries at high risk of adverse drug events: study methods (vol. 4: technology and medication safety).  Rockville, MD:  Agency for Healthcare Research and Quality;  2008.
 
Jarernsiripornkul N, Krska J, Capps PA, Richards RM, Lee A.  Patient reporting of potential adverse drug reactions: a methodological study.  Br J Clin Pharmacol.  2002; 53: 318– 25. [PubMed]
 
Naranjo CA, Busto U, Sellers EM, et al.  A method for estimating the probability of adverse drug reactions.  Clin Pharmacol Ther.  1981; 30: 239– 45. [PubMed]
 
Doucette WR, McDonough RP, Klepser D, McCarthy R.  Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy.  Clin Ther.  2005; 27: 1104– 11. [PubMed]
 
Isetts BJ, Schondelmeyer SW, Artz MB, et al.  Clinical and economic outcomes of medication therapy management services: the Minnesota experience.  J Am Pharm Assoc.  2008; 48: 203– 11.
 
Lee AJ, Boro MS, Knapp KK, et al.  Clinical and economic outcomes of pharmacist recommendations in a Veterans Affairs medical center.  Am J Health Syst Pharm.  2002; 59: 2070– 7. [PubMed]
 
Juurlink DN, Mamdani M, Kopp A, et al.  Drug-drug interactions among elderly patients hospitalized for drug toxicity.  JAMA.  2003; 289: 1652– 8. [PubMed]
 
Lund BC, Carnahan RM, Egge JA, et al.  Inappropriate prescribing predicts adverse drug events in older adults.  Ann Pharmacother.  2010; 44: 957– 63. [PubMed]
 
Machado M, Bajcar J, Guzzo GC, Einarson TR.  Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management.  Ann Pharmacother.  2007; 41: 1770– 81. [PubMed]
 
Machado M, Bajcar J, Guzzo GC, Einarson TR.  Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management.  Ann Pharmacother.  2007; 41: 1569– 82. [PubMed]
 
Machado M, Nassor N, Bajcar JM, et al.  Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management.  Ann Pharmacother.  2008; 42: 1195– 207. [PubMed]
 
Brooks JM, Unni EJ, Klepser DG, et al.  Factors affecting demand among older adults for medication therapy management services.  Res Social Adm Pharm.  2008; 4: 309– 19. [PubMed]
 
McCollum M, Nuffer W, Ellis SL, Turner CJ.  Physician acceptance of pharmacotherapy recommendations made by pharmacy students in a rural pharmacy-based diabetes care and education clinic.  Am J Pharm Educ.  2009; 73( 2): 24. [PubMed]
 
DeName B, Divine H, Nicholas A, et al.  Identification of medication-related problems and health care provider acceptance of pharmacist recommendations in the DiabetesCARE program.  J Am Pharm Assoc.  2008; 48: 731– 6.
 
Rhoads M, Thai A.  Physician acceptance rate of pharmacist recommendations to reduce use of potentially inappropriate medications in the assisted living setting.  Consult Pharm.  2003; 18: 241– 7. [PubMed]
 
Chrischilles EA, Segar ET, Wallace RB.  Self-reported adverse drug reactions and related resource use: a study of community-dwelling persons 65 years of age and older.  Ann Intern Med.  1992; 117: 634– 40. [PubMed]
 
Gandhi TK, Weingart SN, Borus J, et al.  Adverse drug events in ambulatory care.  N Engl J Med.  2003; 348: 1556– 64. [PubMed]
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Please read the other comments before you post yours. Comments are moderated and will appear on the site at the discertion of the editorial staff.
* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content

Customize your page view by dragging & repositioning the boxes below.

JAPhA Articles
PubMed Articles
Advertisement
 
  • Print
  • PDF Download
  • Email
  • Share
  • Get Citation
  • Submit Comment
  • Article Alerts
    Please Wait... Processing your request... Please Wait.
    You must sign in to sign-up for alerts.

    Please confirm that your email address is correct, so you can successfully receive this alert.

  • Letters To Editor
  • Reprints